Lung Cancer
Volume 69, Issue 3 , Pages 307-314 , September 2010

Estimation of an optimal chemotherapy utilisation rate for lung cancer: An evidence-based benchmark for cancer care

  • Susannah Jacob

      Affiliations

    • Collaboration for Cancer Outcomes Research and Evaluation (CCORE), Liverpool Hospital and Faculty of Medicine, University of New South Wales, Sydney, Australia
    • Corresponding Author InformationCorresponding author at: Collaboration for Cancer Outcomes Research and Evaluation (CCORE), Liverpool Hospital, Locked Bag 7103, Liverpool, Sydney, NSW 1871, Australia. Tel.: +61 2 9828 6542; fax: +61 2 9828 6670.
    • ,
  • Elizabeth Hovey

      Affiliations

    • Department of Medical Oncology, Prince of Wales Hospital, Sydney, Australia
    • ,
  • Weng Ng

      Affiliations

    • Collaboration for Cancer Outcomes Research and Evaluation (CCORE), Liverpool Hospital and Faculty of Medicine, University of New South Wales, Sydney, Australia
    • ,
  • Shalini Vinod

      Affiliations

    • Collaboration for Cancer Outcomes Research and Evaluation (CCORE), Liverpool Hospital and Faculty of Medicine, University of New South Wales, Sydney, Australia
    • ,
  • Geoff P. Delaney

      Affiliations

    • Collaboration for Cancer Outcomes Research and Evaluation (CCORE), Liverpool Hospital and Faculty of Medicine, University of New South Wales, Sydney, Australia
    • ,
  • Michael B. Barton

      Affiliations

    • Collaboration for Cancer Outcomes Research and Evaluation (CCORE), Liverpool Hospital and Faculty of Medicine, University of New South Wales, Sydney, Australia

Received 15 September 2009 ,Revised 24 November 2009 ,Accepted 29 November 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0169-5002(09)00594-7

doi: 10.1016/j.lungcan.2009.11.017

Lung Cancer
Volume 69, Issue 3 , Pages 307-314 , September 2010

Article Tools

* Image Usage & Resolution